Cellular Therapy

In the battle against cancer, a powerful ally can turn the tide

Hematopoietic progenitor cells (HPCs) are a vital component of a cancer treatment regimen using high-dose chemotherapy and progenitor cell rescue (HDC-PCR).

The American Red Cross helps hospitals provide access to this powerful therapy.

A Full Range of Services
American Red Cross experts collect progenitor cells and preserve their integrity, following all applicable regulations and rigorous quality controls. Based on the needs of patients, collections can be done at an American Red Cross facility or at an out-patient area in the hospital, clinic, or cancer care center. The Red Cross offers a full range of services, including:

• HPC collection
• Processing, freezing, and shipping of progenitor cells
• Long term storage of progenitor cells
• Quality control testing
• Medical and technical consultation 24 hours / 7 days a week

A Powerful Ally
The American Red Cross offers you the confidence in the quality and depth of resources of our nationwide network of professionals who have been working with hematopoietic progenitor cells for more than 20 years and who are ready to support you in the treatment of your patients. The Red Cross program is distinguished for its:

• Dependability
• State-of-the-art technology
• Competitive service fees
• One of the largest pools of experienced apheresis professionals nationwide
• Proactive quality assurance program
• Strong research program
• Quality testing and safety procedures
• Regulatory compliance.

With over 50 years experience in blood products and over 20 years collecting progenitor cell products, the American Red Cross offers you the expert direction and technical support you need for the processing and care of your patients’ progenitor cell resources.

American Red Cross Cellular Therapy Programs